Table 4.
Women’s contraceptive use status after discontinuation of baseline method among women experiencing the same side effect, by selected characteristics, Honduras, 2006–2007
| Discontinuation with amenorrhea (N=66) | Switched n=22 % |
Discontinued N=44 % |
|---|---|---|
| Side effects interfered with daily activities | 59.1 | 43.2 |
| Side effects interfered with relationship with partner | 27.3 | 20.5 |
| Self-medicated or took home remedies* | 13.6 | 34.1 |
| Sought help from a clinic or health worker** | 63.6 | 36.4 |
| Discussed side effects with 2 or more people* | 95.5 | 79.6 |
| Discussed side effects with partner | 68.2 | 50.0 |
| Discussed side effects with family member(s) | 40.9 | 31.8 |
| Discussed side effects with friends | 9.1 | 9.1 |
| Discussed stopping baseline method with partner before making decision to discontinue | 90.9 | 77.3 |
| Discontinuation with heavy bleeding (N=64) | Switched n=36 % | Discontinued N=28 % |
| Side effects interfered with daily activities | 75.0 | 75.0 |
| Side effects interfered with relationship with partner | 72.2 | 71.4 |
| Self-medicated or took home remedies | 19.4 | 21.4 |
| Sought help from a clinic or health worker | 72.2 | 57.1 |
| Discussed side effects with 2 or more people** | 100.0 | 85.7 |
| Discussed side effects with partner*** | 80.6 | 46.4 |
| Discussed side effects with family member(s) | 38.9 | 42.9 |
| Discussed side effects with friends | 19.4 | 25.0 |
| Discussed stopping baseline method with partner before making decision to discontinue*** | 97.2 | 67.9 |
| Discontinuation with headaches (N=82) | Switched n=36 % | Discontinued N=46 % |
| Side effects interfered with daily activities | 66.7 | 71.7 |
| Side effects interfered with relationship with partner | 41.7 | 47.8 |
| Self-medicated or took home remedies* | 36.1 | 56.5 |
| Sought help from a clinic or health worker | 58.3 | 45.7 |
| Discussed side effects with 2 or more people | 94.4 | 89.1 |
| Discussed side effects with partner | 69.4 | 63.0 |
| Discussed side effects with family member(s) | 33.3 | 43.5 |
| Discussed side effects with friends | 19.4 | 15.2 |
| Discussed stopping baseline method with partner before making decision to discontinue** | 88.9 | 69.6 |
p<0.1;
p<0.05;
p<0.01